News 21 May 2025 GluGene Therapeutics Secures Initial Financial Investor Participation in Series A Financing Round GluGene Therapeutics, a biotechnology company developing advanced adeno-associated virus (AAV) platform technologies for next-generation gene therapies, announced that participation by… GluGene
News 29 Apr 2025 GluGene Therapeutics Publishes Breakthrough Precision-Targeted AAV Platform for Pulmonary Arterial Hypertension in Nature Biomedical Engineering GluGene Therapeutics announced the publication of its research demonstrating the potential for a fundamentally curative gene therapy for pulmonary arterial… GluGene
